Skip to main content

REVIEW article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1483595
This article is part of the Research Topic Immunological Precision Therapeutics: Integrating Multi-Omics Technologies and Comprehensive Approaches for Personalized Immune Intervention View all 16 articles

Spatial Transcriptomics: A New Frontier in Accurate Localization of breast cancer Diagnosis and Treatment

Provisionally accepted
  • 1 Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China
  • 2 Shandong college of traditional chinese medicine ,Department of Student Affair, Yantai, China
  • 3 Breast and Thyroid Surgery, Shandong University of Traditional Chinese Medicine Affiliated Hospital,, Jinan, China

The final, formatted version of the article will be published soon.

    Breast cancer is one of the most prevalent cancers in women globally. Its treatment and prognosis are significantly influenced by the tumor microenvironment and tumor heterogeneity. Precision therapy enhances treatment efficacy, reduces unwanted side effects, and maximizes patients' survival duration while improving their quality of life. Spatial transcriptomics is of significant importance for the precise treatment of breast cancer, playing a critical role in revealing the internal structural differences of tumors and the composition of the tumor microenvironment. It offers a novel perspective in studying the spatial structure and cell interactions within tumors, facilitating more effective personalized treatments for breast cancer. This article will summarize the latest findings in the diagnosis and treatment of breast cancer from the perspective of spatial transcriptomics, focusing on the revelation of the tumor microenvironment, identification of new therapeutic targets, enhancement of disease diagnostic accuracy, comprehension of tumor progression and metastasis, assessment of drug responses, creation of high-resolution maps of tumor cells, representation of tumor heterogeneity, and support for clinical decision-making, particularly in elucidating the tumor microenvironment, tumor heterogeneity, immunotherapy and their correlation with clinical outcomes.

    Keywords: breast cancer, Spatial transcriptome, tumor heterogeneity, Tumor Microenvironment, Immunotherapy

    Received: 20 Aug 2024; Accepted: 23 Sep 2024.

    Copyright: © 2024 Zhang, Gong and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Xiaofei Liu, Breast and Thyroid Surgery, Shandong University of Traditional Chinese Medicine Affiliated Hospital,, Jinan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.